Open original FDA record ↗Recall record
- FDA identifier
- Z-0501-2025
- Company in FDA record
- OrganOx Ltd
- FDA classification date
- Nov 21, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Battery movement led to damage of one of the battery cells causing it to short to the battery retention bracket
Source facts
- Action
- OrganOx issued Important Field Correction Notice letter on 10/15/24 via Fed'X. letter states reason for recall, health risk and action to take: As a result of the investigation into this event, OrganOx has implemented a secondary battery retention mechanism to prevent battery movement due to jarring or impact that could be related to machine transport or movement. The secondary battery retention mechanism will be installed on your machine by OrganOx service personnel no later than 15 December 2024. Recommendations: The metra in your possession continues to be safe and effective in anticipation of this correction and the machine may be used as normal. Should an unexpected rapid decrease in battery voltage occur as noted by alarm from the metra, please determine the impact to the perfusion event and take action if needed. Should this occur, please follow the OrganOx complaints reporting process and quarantine the machine until it can be serviced. Should you have questions about this important Field Correction please contact: Michael Donahue Michael.donahue@organox.com +1 732-948-2175
- Initiated
- 2024-10-15
- Root cause
- Device Design
- Distribution
- California, Texas, Ohio, Florida, New York, Massachusetts, Virginia, Oklahoma, DC, South Carolina and Georgia.
- Recall number
- Z-0501-2025
- Recall status
- Open, Classified
- CDRH record ID
- 210674
- FDA classified
- 2024-11-21
- Recall event number
- 95581